These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7399622)

  • 1. Dopaminergic control of sympathetic tone and blood pressure: evidence in primary hypertension.
    Kolloch R; Kobayashi K; DeQuattro V
    Hypertension; 1980; 2(4):390-4. PubMed ID: 7399622
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of clonidine on central and peripheral nerve tone in primary hypertension.
    Sullivan PA; De Quattro V; Foti A; Curzon G
    Hypertension; 1986 Jul; 8(7):611-7. PubMed ID: 3721561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic control of prolactin and blood pressure: altered control in essential hypertension.
    Sowers JR; Nyby M; Jasberg K
    Hypertension; 1982; 4(3):431-7. PubMed ID: 7068198
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of bromocriptine treatment on prolactin, noradrenaline and blood pressure in hypertensive haemodialysis patients.
    Degli Esposti E; Sturani A; Santoro A; Zuccalà A; Chiarini C; Zucchelli P
    Clin Sci (Lond); 1985 Jul; 69(1):51-6. PubMed ID: 3905210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
    Durrieu G; Senard JM; Tran MA; Rascol A; Montastruc JL
    Clin Neuropharmacol; 1991 Feb; 14(1):84-90. PubMed ID: 2029695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperprolactinaemia and antihypertensive effect of bromocriptine in essential hypertension. Identification of abnormal central dopamine control.
    Stumpe KO; Kolloch R; Higuchi M; Krück F; Vetter H
    Lancet; 1977 Jul; 2(8031):211-4. PubMed ID: 69827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release.
    Mannelli M; Delitala G; De Feo ML; Maggi M; Cuomo S; Piazzini M; Guazzelli R; Serio M
    J Clin Endocrinol Metab; 1984 Jul; 59(1):74-8. PubMed ID: 6725527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma catecholamines and renin in diabetes mellitus. Relationships with posture, age, sodium, and blood pressure.
    Beretta-Piccoli C; Weidmann P; Ziegler W; Glück Z; Keusch G
    Klin Wochenschr; 1979 Jul; 57(13):681-91. PubMed ID: 480858
    [No Abstract]   [Full Text] [Related]  

  • 9. Bromocriptine reduces plasma noradrenaline and 3,4-dihydroxyphenylacetic acid in normal and hypotensive subjects.
    Mercuro G; Rossetti ZL; Tocco L; Rivano CA; Cherchi A; Gessa GL
    Eur J Clin Pharmacol; 1985; 27(6):671-5. PubMed ID: 3987772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced depressor effect of bromocriptine in the DOCA/NaCl hypertensive rat.
    Nagahama S; Chen YF; Oparil S
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H64-70. PubMed ID: 2861750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered dopaminergic modulation of sympathetic nervous system activity in idiopathic edema.
    Catania RA; Sowers JR; Stern N; Tuck ML; Paris J
    J Endocrinol Invest; 1984 Oct; 7(5):461-6. PubMed ID: 6512181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Peripheral presynaptic dopamine receptors control the release of norepinephrine and arterial pressure in humans].
    Mercuro G; Rossetti Z; Rivano AC; Tocco L; Ruscazio M; Stefanini E; Gessa GL; Cherchi A
    Cardiologia; 1987 Jul; 32(7):643-50. PubMed ID: 3690588
    [No Abstract]   [Full Text] [Related]  

  • 13. Noradrenergic activity and silent ischaemia in hypertensive patients with stable angina: effect of metoprolol.
    Lee DD; Kimura S; DeQuattro V
    Lancet; 1989 Feb; 1(8635):403-6. PubMed ID: 2563787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary sodium and potassium-induced transient changes in blood pressure and catecholamine excretion in the Sprague-Dawley rat.
    Battarbee HD; Dailey JW; Meneely GR
    Hypertension; 1983; 5(3):336-45. PubMed ID: 6840821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular effects of bromocriptine and lergotrile in renal and spontaneously hypertensive rats.
    Tadepalli AS; Novak PJ
    Arch Int Pharmacodyn Ther; 1983 Nov; 266(1):93-105. PubMed ID: 6141774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin and sympathetic nervous system responsiveness to adrenergic stimuli in essential hypertension.
    Esler MD; Nestel PJ
    Am J Cardiol; 1973 Oct; 32(5):643-9. PubMed ID: 4744694
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of bromocriptine on plasma catecholamines in normal men.
    Van Loon GR; Sole MJ; Bain J; Ruse JL
    Neuroendocrinology; 1979; 28(6):425-34. PubMed ID: 460538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressed plasma renin activity in essential hypertension. Roles of plasma volume, blood pressure, and sympathetic nervous system.
    Jose A; Crout JR; Kaplan NM
    Ann Intern Med; 1970 Jan; 72(1):9-16. PubMed ID: 4312105
    [No Abstract]   [Full Text] [Related]  

  • 20. Endocrine and cardiovascular influences of converting enzyme inhibition with SQ 14225 in hypertensive patients in the supine position and during head-up tilt before and after sodium depletion.
    Morganti JA; Pickering TG; Lopez-Ovejero JA; Laragh JH
    J Clin Endocrinol Metab; 1980 Apr; 50(4):748-54. PubMed ID: 6245101
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.